The couta who kicked the hornets' nest
Quote:
Originally Posted by
couta1
Peb had just slipped off page one for the first time in a long while meanwhile it goes sub 70c for a 26wk low and buyers looking thin-Lol
and you could have let it be.
By the way my broker says that PEB buyers have a normal distribution of body shapes and are in no way nutritionally challenged - but what would he know?
Best Wishes
Paper Tiger
You may be using the wrong basis there
Quote:
Originally Posted by
MAC
Actually, running the numbers on those results;
https://www.nzx.com/files/attachments/209911.pdf
If 5.7 lots of tests were performed within HY15, and 14.8 lots of tests were performed within the second half, then that’s a total for the FY15 financial year to 31 March, of 20.5 lots of tests.
Roughly then, and coarsely assuming similar historical ratios to test to sales;
We may thus anticipate FY15 revenues of ;
[ HY15 revenues $1.6 x (21.2 / 5.5) ] = $5.7M revenues at FY15 !
Analyst consensus is only $3.2M, we may thus very well see a substantial outperform here.
Lab sales (trading revenue) for the first half were:
NZ $71K;
USA $460K
It is these numbers which you can multiply up for full year to:
NZ $255K
USA $1654K
Total $1910K
I am assuming some assumptions here and hope that:
"Q4 FY15 has also been subject to lower results due to the introduction of the Affordable Care Act in January 2015" is a transitory effect and not a new normal.
Then add on the other stuff to the income for your FY guess.
Best Wishes
Paper Tiger